1. Home
  2. NCLH vs VTAK Comparison

NCLH vs VTAK Comparison

Compare NCLH & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Norwegian Cruise Line Holdings Ltd.

NCLH

Norwegian Cruise Line Holdings Ltd.

HOLD

Current Price

$19.50

Market Cap

8.4B

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.08

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCLH
VTAK
Founded
1966
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
3.0M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
NCLH
VTAK
Price
$19.50
$1.08
Analyst Decision
Buy
Analyst Count
17
0
Target Price
$24.76
N/A
AVG Volume (30 Days)
19.2M
58.8K
Earning Date
05-04-2026
08-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.53
EPS
0.23
N/A
Revenue
$5,396,175,000.00
$442,000.00
Revenue This Year
$9.96
$1,170.33
Revenue Next Year
$6.60
N/A
P/E Ratio
$82.87
N/A
Revenue Growth
10.71
3057.14
52 Week Low
$14.53
$0.15
52 Week High
$27.18
$4.31

Technical Indicators

Market Signals
Indicator
NCLH
VTAK
Relative Strength Index (RSI) 60.86 59.87
Support Level $17.66 $0.77
Resistance Level $20.82 $1.28
Average True Range (ATR) 0.83 0.09
MACD 0.24 0.02
Stochastic Oscillator 97.89 68.36

Price Performance

Historical Comparison
NCLH
VTAK

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 17 passenger vessels on order among its brands through 2037, representing 46,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

Share on Social Networks: